Answers are grounded in this paper and cite their sources.
Advancements explored equitable diagnosis in dementia, suggesting systemic shifts for better outcomes.
The field of Alzheimer's disease and related dementias (AD/ADRD) is undergoing a transformative shift with a better understanding of disease biology, biomarker‐based diagnostics, and disease‐modifying therapies. Yet, these advancements risk exacerbating existing disparities in diagnosis and care. The 2024 Alzheimer's Association International Conference (AAIC) Advancements: Exploring Equity in Diagnosis convened interdisciplinary experts to address these inequities and chart a path toward population‐generalizable research and practice. This article synthesizes key insights from the conference, highlighting considerations for inclusive and representative research design, ethical approaches in diagnostic disclosure, as well as challenges and solutions at individual, community, and systemic levels to advance equity in dementia diagnosis. Mitigating disparities in dementia diagnosis requires a paradigm shift—embedding justice and inclusion at every level of AD/ADRD research, diagnosis, and care.
No takes yet. Share an insight, caveat, or question.
Neumann et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: